Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomePreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Capital Expenditures (2016 - 2025)

DarioHealth filings provide 13 years of Capital Expenditures readings, the most recent being $26000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 23.81% to $26000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $142000.0, a 2.9% increase, with the full-year FY2025 number at $142000.0, up 2.9% from a year prior.
  • Capital Expenditures hit $26000.0 in Q4 2025 for DarioHealth, down from $41000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $281000.0 in Q3 2023 to a low of $21000.0 in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $61000.0 (2022), compared with a mean of $78350.0.
  • Biggest five-year swings in Capital Expenditures: surged 448.28% in 2022 and later crashed 88.61% in 2024.
  • DarioHealth's Capital Expenditures stood at $68000.0 in 2021, then plummeted by 36.76% to $43000.0 in 2022, then surged by 93.02% to $83000.0 in 2023, then tumbled by 74.7% to $21000.0 in 2024, then rose by 23.81% to $26000.0 in 2025.
  • The last three reported values for Capital Expenditures were $26000.0 (Q4 2025), $41000.0 (Q3 2025), and $44000.0 (Q2 2025) per Business Quant data.